Serum lactate dehydrogenase predicts prognosis and correlates with systemic inflammatory response in patients with advanced pancreatic cancer after gemcitabine-based chemotherapy

Serum lactate dehydrogenase (LDH) concentrations correlate with tumor progression and poor outcome. We evaluated the predictive value of serum LDH level for overall survival (OS) of patients with advanced pancreatic cancer after gemcitabine-based chemotherapy. We retrospectively enrolled 364 patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Shu-Lin, Xu, Li-Tao, Qi, Qi, Geng, Ya-Wen, Chen, Hao, Meng, Zhi-Qiang, Wang, Peng, Chen, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366928/
https://www.ncbi.nlm.nih.gov/pubmed/28345594
http://dx.doi.org/10.1038/srep45194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366928/
https://www.ncbi.nlm.nih.gov/pubmed/28345594
http://dx.doi.org/10.1038/srep45194

Ejemplares similares